Creutzfeldt-Jakob Disease
Creutzfeldt-Jakob Disease (CJD) is a rare, degenerative and fatal neurological disorder that affects the brain and nervous system. It belongs to a group of diseases known as transmissible spongiform encephalopathies (TSEs), also called prion diseases. The disease is caused by a misfolded protein called a prion that affects the normal function of brain cells, leading to their death. CJD is characterized by rapidly progressive dementia, behavioral changes, and a range of neurological symptoms, such as muscle stiffness, involuntary movements, and coordination problems. The disease usually progresses rapidly and can eventually lead to coma and death within a year of onset. There are several different types of CJD, including sporadic CJD, which occurs spontaneously without any known cause; inherited CJD, which is caused by genetic mutations that affect the production of prions; and acquired CJD, which is caused by exposure to contaminated brain or nervous tissue, such as from contaminated surgical instruments or human growth hormone. As of yet, there are no definitive treatments for CJD. Treatment measures aim to relieve symptoms and provide supportive care. However, research into novel therapies for CJD and other prion diseases is ongoing, including experimental drugs and protein-targeting approaches. In summary, CJD is a rare and fatal neurological disease caused by misfolded prion proteins that affect the normal function of brain cells, leading to rapidly progressive dementia and a range of neurological symptoms. While there is no cure for CJD, ongoing research offers hope for future treatments.
← Journal of Neurological Research And Therapy